Clinical Trials Directory

Trials / Completed

CompletedNCT04653662

Earol Madrid Study

Multi-center, Open-label, Non-randomized, Single-arm Clinical Study to Assess the Safety and Performance of Earol® in Adult Patients With Ear Wax

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
HL Healthcare Ltd · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Accumulation of ear wax in the external ear canal is a common pathology. The presence of ear wax not only interferes with the clinician's view of the tympanic membrane, but may also result in hearing loss and vertigo, and may predispose to ear infections. Removal of ear wax is facilitated using a variety of cerumenolytics, or ear wax solvents. The current study is designed to evaluate the safety and the cerumenolytic effects of the Earol product, when dosed into the auditory canal prior to the dewaxing and ear cleaning procedure. This study is designed to be conducted in the primary care setting as a prospective clinical trial. A detailed literature review has been conducted to provide a background summary of relevant information on the disease/pathology, other available treatment options and the pre-clinical testing and clinical research that has been conducted to date on the intended population or related populations and/or the device. The aim for conducting this clinical investigation is to perform a PMCF to evaluate the safety and performance of Earol. Although there are alternative methods for ear wax removal, Earol represents a simple method based on natural ingredients (olive oil) which aids the removal of ear wax as well as prevents appearance of clinical symptoms in the ear canal (E.g. reducing itching and irritation).

Conditions

Interventions

TypeNameDescription
DEVICEEarolTreated with Earol on both ears and subsequent removal after 6 days of application

Timeline

Start date
2019-12-03
Primary completion
2021-06-17
Completion
2022-01-26
First posted
2020-12-04
Last updated
2023-03-20

Locations

5 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04653662. Inclusion in this directory is not an endorsement.